NCT06372054

Brief Summary

The goal of this observational study is to define a personalized risk model in the super healthy and homogeneous population of Italian Air Force high-performance pilots. This peculiar cohort conducts dynamic activities in an extreme environment, compared to a population of military people not involved in flight activity. The study integrates the analyses of biological samples (urine, blood, and saliva), clinical records, and occupational data collected at different time points and analyzed by omic-based approaches supported by Artificial Intelligence. Data resulting from the study will clarify many etiopathological mechanisms of diseases, allowing the creation of a model of analyses that can be extended to the civilian population and patient cohorts for the potentiation of precision and preventive medicine.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
10mo left

Started Feb 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Feb 2024Feb 2027

Study Start

First participant enrolled

February 5, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2027

Expected
Last Updated

April 17, 2024

Status Verified

March 1, 2024

Enrollment Period

1 year

First QC Date

March 21, 2024

Last Update Submit

April 16, 2024

Conditions

Keywords

pilotsair forceepigenetic changeenvironmental exposure

Outcome Measures

Primary Outcomes (1)

  • Assessment of flight-related exposure data and molecular modifications

    Collection of information on: i) lifestyle, ii) medical examination, iii) previous trauma, iv) cumulative professional exposure to flying, determination of panel of genes and circulating markers to assess prognostic and predictive factors

    Through study completion, an average of 3 year

Secondary Outcomes (4)

  • Assessment of General Health

    Through study completion, an average of 3 year

  • Assessment of Sleep Quality

    Through study completion, an average of 3 year

  • Assessment of eating habits

    Through study completion, an average of 3 year

  • Creation of reliable AI and disease-based models for personalized medicine

    Through study completion, an average of 3 year

Study Arms (2)

High-performance Italian Air Force Pilots

The primary study cohort is represented by "super-healthy" high-performance Italian Air Force Pilots, aged between 26 and 38 years, in active flight service. Intervention: not applicable

Other: Biological sample collection

Italian Air Force ground staff

This cohort of Italian Air Force ground personnel will be used as a control group to compare data from the pilot cohort.

Other: Biological sample collection

Interventions

Collection of biological samples (blood, urine, saliva) and clinical data

High-performance Italian Air Force PilotsItalian Air Force ground staff

Eligibility Criteria

Age26 Years - 38 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of high-performance Italian Air Force pilots, compared to Italian Air Force ground staff.

You may qualify if:

  • Being part of the Italian Air Force, as in active flight service or ground staff
  • Age between 26 and 38 years
  • Consent to collect biological samples and use the wearable device to monitor exposure parameters

You may not qualify if:

  • Age \< 25 years and \> 39 years
  • no signature on informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CeMATA - Joint Center for Aerospace Medicine and Advanced Therapy

Milan, 20139, Italy

RECRUITING

Related Publications (2)

  • Marfia G, Navone SE, Guarnaccia L, Campanella R, Locatelli M, Miozzo M, Perelli P, Della Morte G, Catamo L, Tondo P, Campanella C, Lucertini M, Ciniglio Appiani G, Landolfi A, Garzia E. Space flight and central nervous system: Friends or enemies? Challenges and opportunities for neuroscience and neuro-oncology. J Neurosci Res. 2022 Sep;100(9):1649-1663. doi: 10.1002/jnr.25066. Epub 2022 Jun 9.

  • Marfia G, Guarnaccia L, Navone SE, Ampollini A, Balsamo M, Benelli F, Gaudino C, Garzia E, Fratocchi C, Di Murro C, Ligarotti GK, Campanella C, Landolfi A, Perelli P, Locatelli M, Ciniglio Appiani G. Microgravity and the intervertebral disc: The impact of space conditions on the biomechanics of the spine. Front Physiol. 2023 Mar 14;14:1124991. doi: 10.3389/fphys.2023.1124991. eCollection 2023.

Biospecimen

Retention: SAMPLES WITH DNA

Blood, urine, salivae

Study Officials

  • Giovanni Marfia, MD, PhD

    Fondazione IRCCs Ca' Granda Ospedale MAggiore Policlinico, Italian Air Force

    PRINCIPAL INVESTIGATOR
  • Emanuele Garzia, MD, PhD

    Italian Air Force

    STUDY CHAIR
  • Marco Locatelli, MD, PhD

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    STUDY CHAIR
  • Francesco Vestito, PhD

    Italian Air Force

    STUDY CHAIR

Central Study Contacts

Giovanni Marfia, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2024

First Posted

April 17, 2024

Study Start

February 5, 2024

Primary Completion

February 5, 2025

Study Completion (Estimated)

February 5, 2027

Last Updated

April 17, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Subject's data will be collected in completely anonymized form.

Locations